COVID-19 vaccine effective in elderly says AstraZeneca after German govt doubts efficacy

Earlier reports said that the AstraZeneca/Oxford vaccine efficacy is as low as eight percent in adults over 65 years.

Agence France-Presse January 26, 2021 11:55:19 IST
COVID-19 vaccine effective in elderly says AstraZeneca after German govt doubts efficacy

Pharma giant AstraZeneca has defended the efficacy of its COVID-19 vaccine after media reports said the German government had doubts about its effectiveness among those over 65. The Handelsblatt economic daily reported Monday that Berlin had estimated the efficacy of the jab among over-65s was just eight percent, citing sources. Bild also said that Berlin did not expect the vaccine — developed with Oxford University and set to get the green light from the EU this week — would receive a license for use in the elderly, presenting a significant challenge to rollout plans in many countries.

"Reports that the AstraZeneca/Oxford vaccine efficacy is as low as eight percent in adults over 65 years are completely incorrect," the firm said in a statement late Monday.

"In November, we published data in The Lancet demonstrating that older adults showed strong immune responses to the vaccine, with 100 percent of older adults generating spike-specific antibodies after the second dose," it added.

The European Union issued an angry warning to AstraZeneca Monday over its unexpected delay in delivering millions of doses of its COVID-19 vaccine to the bloc.

Last Friday, the pharma giant said it would not meet its contractual delivery commitments to the European Union because of unexplained "reduced yields" in its European supply chain.

The European Union has currently authorised two vaccines for widespread distribution, manufactured by BioNTech/Pfizer and Moderna.

It was set to add the AstraZeneca vaccine to that list this week, on the understanding that it would be already on hand and available for immediate roll-out.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

First dose of Pfizer, AstraZeneca shots cut transmission, hospitalisation risk, say UK studies
World

First dose of Pfizer, AstraZeneca shots cut transmission, hospitalisation risk, say UK studies

Being the first nation to begin mass vaccinations in December, over 17 million UK resident have received at least a first dose so far.

Coronavirus News Updates: Delhi HC questions controlled vaccination drive; Maharashtra, Kerala continue to see upsurge in cases
India

Coronavirus News Updates: Delhi HC questions controlled vaccination drive; Maharashtra, Kerala continue to see upsurge in cases

Maharashtra also displayed a rise in active cases in 24 hrs followed by Punjab, Rajasthan, Chhattisgarh, Madhya Pradesh, Haryana and Gujarat, the health ministry said

AstraZeneca vaccine is 80.4%, Pfizer vaccine is 71.4% effective in elderly people: Study
science

AstraZeneca vaccine is 80.4%, Pfizer vaccine is 71.4% effective in elderly people: Study

Although the vaccine developers and WHO insist that the vaccine is effective among people aged over 65, several countries advise against administering it.